Laboratorio Reig Jofre S.A (RJF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Laboratorio Reig Jofre S.A (RJF) has a cash flow conversion efficiency ratio of 0.056x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€11.35 Million ≈ $13.27 Million USD) by net assets (€202.27 Million ≈ $236.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Laboratorio Reig Jofre S.A market capitalisation for the company's overall valuation and market capitalisation.
Laboratorio Reig Jofre S.A - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Laboratorio Reig Jofre S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Laboratorio Reig Jofre S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Laboratorio Reig Jofre S.A ranked by their cash flow conversion efficiency. Explore Laboratorio Reig Jofre S.A earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CF Bankshares Inc
NASDAQ:CFBK
|
0.026x |
|
Grupo Ecoener S.A.
MC:ENER
|
-0.170x |
|
Stellus Capital Investment
NYSE:SCM
|
154752.995x |
|
China General Plastics Corp
TW:1305
|
0.025x |
|
SHANDONG BOAN BIOTECH.H 1
F:UJ9
|
N/A |
|
EVI Industries Inc
NYSE MKT:EVI
|
0.007x |
|
HUA YU LIEN Development Co Ltd
TW:1436
|
-0.026x |
|
Highlight Tech
TWO:6208
|
0.040x |
Annual Cash Flow Conversion Efficiency for Laboratorio Reig Jofre S.A (2005–2024)
The table below shows the annual cash flow conversion efficiency of Laboratorio Reig Jofre S.A from 2005 to 2024. View RJF stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €213.95 Million ≈ $250.13 Million |
€31.34 Million ≈ $36.64 Million |
0.146x | +56.52% |
| 2023-12-31 | €204.25 Million ≈ $238.79 Million |
€19.11 Million ≈ $22.35 Million |
0.094x | +12.76% |
| 2022-12-31 | €194.55 Million ≈ $227.45 Million |
€16.15 Million ≈ $18.88 Million |
0.083x | +7.92% |
| 2021-12-31 | €188.51 Million ≈ $220.39 Million |
€14.50 Million ≈ $16.95 Million |
0.077x | -36.96% |
| 2020-12-31 | €184.48 Million ≈ $215.67 Million |
€22.50 Million ≈ $26.31 Million |
0.122x | +86.07% |
| 2019-12-31 | €178.14 Million ≈ $208.26 Million |
€11.68 Million ≈ $13.65 Million |
0.066x | -33.51% |
| 2018-12-31 | €149.74 Million ≈ $175.06 Million |
€14.77 Million ≈ $17.26 Million |
0.099x | -32.54% |
| 2017-12-31 | €141.56 Million ≈ $165.50 Million |
€20.69 Million ≈ $24.19 Million |
0.146x | +1407.90% |
| 2016-12-31 | €133.29 Million ≈ $155.83 Million |
€-1.49 Million ≈ $-1.74 Million |
-0.011x | -110.96% |
| 2015-12-31 | €126.17 Million ≈ $147.51 Million |
€12.87 Million ≈ $15.05 Million |
0.102x | +464.70% |
| 2014-12-31 | €118.17 Million ≈ $138.16 Million |
€-3.31 Million ≈ $-3.86 Million |
-0.028x | -110.13% |
| 2014-09-30 | €44.70 Million ≈ $52.26 Million |
€12.34 Million ≈ $14.43 Million |
0.276x | +5171.62% |
| 2013-12-31 | €75.62 Million ≈ $88.40 Million |
€396.00K ≈ $462.97K |
0.005x | +107.71% |
| 2012-12-31 | €86.75 Million ≈ $101.42 Million |
€-5.89 Million ≈ $-6.89 Million |
-0.068x | +17.29% |
| 2011-12-31 | €86.59 Million ≈ $101.23 Million |
€-7.11 Million ≈ $-8.31 Million |
-0.082x | -19.89% |
| 2010-12-31 | €73.35 Million ≈ $85.76 Million |
€-5.02 Million ≈ $-5.87 Million |
-0.068x | +72.68% |
| 2009-12-31 | €93.59 Million ≈ $109.41 Million |
€-23.46 Million ≈ $-27.43 Million |
-0.251x | -284.90% |
| 2008-12-31 | €131.95 Million ≈ $154.26 Million |
€17.89 Million ≈ $20.91 Million |
0.136x | -39.48% |
| 2007-12-31 | €140.91 Million ≈ $164.74 Million |
€31.57 Million ≈ $36.91 Million |
0.224x | +384.08% |
| 2006-12-31 | €147.74 Million ≈ $172.72 Million |
€6.84 Million ≈ $7.99 Million |
0.046x | +135.58% |
| 2005-12-31 | €79.25 Million ≈ $92.65 Million |
€-10.31 Million ≈ $-12.05 Million |
-0.130x | -- |
About Laboratorio Reig Jofre S.A
Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables … Read more